Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension

OBJECTIVE: To demonstrate that the intraocular pressure (IOP)-lowering efficacy of a twice-daily brinzolamide 10 mg/mL (BRINZ)/brimonidine 2 mg/mL (BRIM) fixed-dose combination (BBFC) was non-inferior to its individual components (BRINZ+BRIM) dosed concomitantly in patients with open-angle glaucoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ningli, Lu, Da-Wen, Pan, Yingzi, Astakhov, Yury, Iureva, Tatyana, Adewale, Adeniyi, Walker, Thomas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986681/
https://www.ncbi.nlm.nih.gov/pubmed/32158181
http://dx.doi.org/10.2147/OPTH.S231402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986681/
https://www.ncbi.nlm.nih.gov/pubmed/32158181
http://dx.doi.org/10.2147/OPTH.S231402

Ejemplares similares